Figure 3a.
Dose response analysis of samples 1 (OSME), 2 (PGAE), 3 (PFFP), 4 (PGPP), and 5 (AZLP) along with acyclovir (ACV), HSV-2 virus control and cell controls in a 96-well plate following CPE inhibition assay
Dose response analysis of samples 1 (OSME), 2 (PGAE), 3 (PFFP), 4 (PGPP), and 5 (AZLP) along with acyclovir (ACV), HSV-2 virus control and cell controls in a 96-well plate following CPE inhibition assay